You are here

autoimmune disease

In wake of Eli Lilly setback, Merck KGaA’s leading BTK drug for autoimmune disease clears PhIIb hurdle

Endpoints

Fri, 03/9/18 - 10:48 am

autoimmune disease

AstraZeneca spinout bags $250M, pipeline headed by late-phase autoimmune drug

Fierce Biotech

Wed, 02/28/18 - 11:16 am

autoimmune disease

Here's Where Things Went Wrong for Celgene Corporation in 2017

Motley Fool

Fri, 12/29/17 - 10:44 am

autoimmune disease

Powerful new cancer drugs are saving lives, but can also ignite diabetes or other autoimmune conditions

Science

Fri, 11/17/17 - 11:24 am

checkpoint inhibitors

autoimmune disease

type 1 diabetes

Merck strikes autoimmune deal with newly-emerged Cue

BioPharma Dive

Fri, 11/17/17 - 10:18 am

autoimmune disease

drug development

J&J goes back to Ionis for its second experimental pill for a GI autoimmune disease

Endpoints

Thu, 11/16/17 - 11:08 am

Ionis Pharmaceuticals

autoimmune disease

IONIS-JBI2-2.5Rx

Novartis strengthens autoimmune indications for Cosentyx

PM Live

Fri, 11/10/17 - 10:21 pm

autoimmune disease

psoriatic arthritis

ankylosing spondylitis

Big pharma stands to make hundreds of billions of dollars from a handful of medical conditions

Motley Fool

Thu, 09/7/17 - 09:56 am

viral hepatitis

respiratory disease

autoimmune disease

cardiovascular disease

Horizon CEO Tim Walbert knows patients because he is one

Medical Marketing and Media

Wed, 08/23/17 - 11:39 am

autoimmune disease

Eli Lilly offers $400M-plus deal to bag an early-stage autoimmune drug from Nektar

Endpoints

Mon, 07/24/17 - 10:46 am

autoimmune disease

AbbVie's Eagerly Anticipated Followup to Humira Is Coming: What You Need to Know

Motley Fool

Fri, 06/23/17 - 03:37 pm

autoimmune disease

Inside the small Norwood biotech that's making investors swoon

Bizjournals.com

Fri, 03/17/17 - 09:28 am

Corbus Pharmaceuticals

autoimmune disease

Did Biogen Just Throw in the Towel to Celgene?

Motley Fool

Wed, 01/4/17 - 10:49 am

autoimmune disease

Celgene Boldly Targeting $6 Billion (or More) in New Business

Motley Fool

Tue, 11/1/16 - 09:49 am

autoimmune disease

Biogen quietly whisks away its $544M autoimmune rival to Celgene

Endpoints

Wed, 10/26/16 - 09:28 am

autoimmune disease

Celgene Is Building an Autoimmune Empire -- and No One Is Talking About It

Motley Fool

Sun, 10/2/16 - 10:19 am

autoimmune disease

The Most Exciting Drug in Celgene's Pipeline

Motley Fool

Wed, 09/21/16 - 10:46 pm

autoimmune disease

Eisai launches research division in Massachusetts aimed at Alzheimer’s, I/O and autoimmune diseases

Endpoints

Thu, 09/15/16 - 09:29 am

Alzheimer's disease

autoimmune disease

Allergan to acquire Vitae Pharma in an all-cash deal valued at about $639 million

Marketwatch

Wed, 09/14/16 - 09:51 am

autoimmune disease

How AbbVie Plans To Replace Humira

Seeking Alpha

Tue, 04/12/16 - 07:43 am

autoimmune disease

Pages